GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: study protocol.

Philippe RouanetFlorence CastanThibault MazardClaire LemanskiStephanie NougaretEmmanuel DeshayesPatrick ChalbosSophie GourgouChristophe Taoumnull null

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)

If GRECCAR 14 demonstrates the ability to tailor TNT for LARC, this could lead to changes in clinical practice.

Keyphrases

phase ii
open label
locally advanced
clinical trial
rectal cancer
placebo controlled
double blind
study protocol
phase iii
clinical practice
phase ii study
squamous cell carcinoma
neoadjuvant chemotherapy
randomized controlled trial
radiation therapy
smoking cessation